VR therapy and mental health

JRCT ID: jRCT1032240289

Registered date:22/08/2024

Basic Information

• Recruitment status: Recruiting
• Health condition(s) or Problem(s) studied: Patients with anxiety and insomnia.
• Date of first enrollment: 22/08/2024
• Target sample size: 20
• Study type: Interventional

Intervention(s)

Participants will wear the Meta Quest 2 and watch VR for a total of eight sessions over a four-week period.
This will be up to two times a week, and each session will last 20 minutes.

Outcome(s)

• Primary Outcome: Rate of change in Generalized Anxiety Disorder-7 (GAD-7)
• Secondary Outcome: Rate of change in Pittsburgh sleep quality index (PSQI)

Key inclusion & exclusion criteria

• Age minimum: >= 18age old
• Age maximum: < 60age old
• Gender: Both

Include criteria

1) Adults aged 18 to 60 years
2) Patients currently receiving treatment for anxiety and insomnia
3) Patients with a score of 5 or higher on the Generalized Anxiety Disorder Questionnaire (GAD-7)
4) Patients with a score of 6 or higher on the Pittsburgh Sleep Quality Index (PSQI)
5) Patients who understand and consent to using VR devices

Exclude criteria

1) Patients whose health may be adversely affected by the use of VR devices (symptoms of severe epilepsy or dizziness)
2) Pregnant or potentially pregnant patients
3) Patients with restrictive physical conditions (severe visual or hearing impairments)
4) Patients who are unable to create an environment requiring Wi-Fi connection
5) Patients with a score of less than 5 on the Generalized Anxiety Disorder Questionnaire (GAD-7)
6) Patients with a score of less than 6 on the Pittsburgh Sleep Quality Index (PSQI)
7) Other individuals who the principal investigator judges to be unsuitable based on their current medical history, medical treatment history, disease name, etc.

Related Information

• Primary Sponsor: Katsuta Narimasa